Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Vistra Corp — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B), while Vistra Corp trades at $161.2 (market cap $52.41B). The key difference: Vistra Corp is far larger — about 2.1× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and Vistra Corp for 32 Days on average.
| RPRX | VST | |
|---|---|---|
Market Cap | $25.27B | $52.41B |
Volume | 3,671,183 | 11,278,074 |
Sector | Health | Utilities |
52-Week High | $63.96 | $210.85 |
52-Week Low | $35.44 | $134.71 |
Typical Hold Time | 1 Days | 32 Days |
Enterprise Value | $32.50B | $74.34B |
Dividend Yield | 1.66% | 0.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Vistra Corp. (VST) trades at $161.48, down 3.14% on the day, amid mixed earnings history but strong analyst support. Technicals are bullish with support at $152 and resistance at $164, while fundamentals show robust profitability with an 11.55% net margin and 75.73% ROE. Recent developments include a $4.2 billion US loan for nuclear expansion and a 20-year power deal with New Era Energy, positioning Vistra to capitalize on AI-driven electricity demand.
The outlook is positive with a consensus price target of $215.23 implying 33% upside, driven by nuclear scale and data center partnerships. Risks include earnings volatility and high debt, but institutional bullishness and AI power scarcity trends offer a compelling growth narrative for investors seeking exposure to the energy transition.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
